Eastman Chemical Company (EMN) reported first-quarter 2025 earnings of $1.57 per share, reflecting a rise of 12.9% from the year-ago quarter's figure of $1.39.EMN posted adjusted earnings of $1.91 per share, up 18.6% from the year-ago quarter figure of $1.61. It surpassed the Zacks Consensus Estimate of $1.89.The company’s revenues in the first quarter were $2,290 million, which missed the Zacks Consensus Estimate of $2,308.6 million. Sales decreased around 1% from $2,310 million reported in the prior-year ...

Core Viewpoint - Service Corporation International (SCI) is expected to show growth in both revenue and earnings for the first quarter of 2025, with revenue estimates at $1.05 billion and earnings per share at 90 cents, reflecting increases from the previous year [1][2]. Group 1: Revenue and Earnings Estimates - The Zacks Consensus Estimate for SCI's revenues is $1.05 billion, indicating a 0.8% increase from the prior-year quarter [1]. - The consensus estimate for quarterly earnings per share is 90 cents, suggesting a 1.1% increase from the figure reported in the year-ago quarter [1]. - The Cemetery segment is projected to generate revenues of $446.4 million, up from $440.6 million in the previous year, while the Funeral segment is expected to contribute $607.3 million, slightly up from $604.7 million [3]. Group 2: Business Model and Strategic Positioning - SCI benefits from a recession-resilient business model and a diverse portfolio, including pre-need and at-need funeral and cemetery services [2]. - Favorable demographics, such as the aging baby boomer population and urbanization trends, position the company well for growth [2]. - Strategic investments in high-growth regions like California, Florida, and Texas, along with acquisitions of funeral homes and cemeteries, enhance SCI's service capabilities [2]. Group 3: Earnings Prediction and Market Position - The current Zacks Rank for SCI is 4 (Sell), and the Earnings ESP is 0.00%, indicating that the model does not predict an earnings beat this time [4]. - The company has a trailing four-quarter negative earnings surprise of 0.6% on average [1].

Portland General Electric (POR) came out with quarterly earnings of $0.91 per share, missing the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $1.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.15%. A quarter ago, it was expected that this electric utility would post earnings of $0.32 per share when it actually produced earnings of $0.34, delivering a surprise of 6.25%.Over the last four quart ...

Universal Insurance Holdings (UVE) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 28.57%. A quarter ago, it was expected that this property and casualty insurance company would post earnings of $0.09 per share when it actually produced earnings of $0.25, delivering a surprise of 177 ...

Boston Beer (SAM) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 176.92%. A quarter ago, it was expected that this brewer would post a loss of $1.18 per share when it actually produced a loss of $1.68, delivering a surprise of -42.37%. Over the last four quarters, the company has s ...

Core Viewpoint - Ecolab, Inc. is set to report its first-quarter 2025 results, with expectations of mixed performance across its segments, influenced by both growth opportunities and challenges in the current macroeconomic environment [1][9]. Global Industrial Segment - The Global Industrial segment, which includes Water, Food & Beverage, and Paper units, experienced sales growth in Q4 2024, particularly in the Water business, which is expected to positively impact overall industrial performance in the midterm [2][3]. - The Zacks Consensus Estimate for Q1 2025 revenues in the Global Industrial segment is $1.92 billion, reflecting a 4.1% increase from the previous year [4]. Global Institutional & Specialty Segment - The Global Institutional & Specialty segment showed strong growth in the last reported quarter, driven by new business and customer penetration, with expectations of continued revenue growth in Q1 2025 [5]. - The Zacks Consensus Estimate for Q1 2025 revenues in this segment is $1.37 billion, indicating a 7.9% increase from the prior year [6]. Other Contributing Factors - Ecolab's Life Sciences unit and Global Pest Elimination segment are also expected to contribute positively to revenues, with good new business wins and ongoing digital initiatives [7]. - However, the exit from non-strategic low-margin businesses in the Global Healthcare & Life Sciences segment may negatively impact performance [8]. Overall Revenue and EPS Estimates - The total revenue estimate for Q1 2025 is $3.70 billion, which represents a 1.4% decline from the previous year [9]. - The consensus estimate for EPS is $1.51, suggesting a 12.7% improvement from the prior-year period [10]. Share Price Performance - Over the past three months, Ecolab's shares have decreased by 3.6%, outperforming the Chemical - Specialty sector's decline of 6.6% and the S&P 500's decline of 10.9% [13]. - Comparatively, peers like Hawkins, Inc. and Givaudan SA have outperformed Ecolab, while Balchem Corporation has underperformed [17]. Valuation Metrics - Ecolab's forward 12-month price-to-earnings (P/E) ratio is 30.4X, which is higher than the industry average of 22.1X, indicating a premium valuation [18]. - The company trades at a premium compared to Hawkins but at a discount to peers like Balchem and Givaudan [19]. Long-Term Investment Outlook - Ecolab is making significant strides in its Global Water business and has engaged in partnerships to enhance water safety and efficiency, which are expected to bolster long-term growth [20]. - The Global Institutional & Specialty and Global Pest Elimination segments are aligning with long-term growth objectives, raising optimism about their profitability prospects [21]. Final Assessment - Ecolab demonstrates strong core business strength and growth potential, making it a suitable hold for existing investors [22]. - However, for new investors, the current valuation suggests limited growth potential compared to industry peers, advising caution before adding to positions [23].

Core Viewpoint - Cardiff Oncology is expected to report a year-over-year increase in earnings despite lower revenues, with the actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $0.19 per share, reflecting a year-over-year change of +13.6% [3]. - Revenues are projected to be $0.17 million, down 19.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 9.52% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Cardiff Oncology is higher than the Zacks Consensus Estimate, leading to an Earnings ESP of +24.32% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Cardiff Oncology currently holds a Zacks Rank of 2, suggesting a high likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Cardiff Oncology was expected to post a loss of $0.25 per share but delivered a loss of $0.21, resulting in a surprise of +16% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [13]. Conclusion - Cardiff Oncology is positioned as a compelling earnings-beat candidate, but investors should consider other factors influencing stock performance beyond earnings results [16].

Core Viewpoint - The market anticipates a year-over-year decline in Esab's earnings due to lower revenues, with a focus on how actual results compare to estimates to influence stock price [1][2]. Earnings Expectations - Esab is expected to report quarterly earnings of $1.18 per share, reflecting a -1.7% change year-over-year, with revenues projected at $630.56 million, down 8.6% from the previous year [3]. - The consensus EPS estimate has been revised 1.32% lower in the last 30 days, indicating a bearish sentiment among analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Esab is lower than the consensus estimate, resulting in an Earnings ESP of -2.54%, suggesting a challenging outlook for beating estimates [10][11]. - Esab currently holds a Zacks Rank of 3, complicating predictions for an earnings beat [11]. Historical Performance - In the last reported quarter, Esab exceeded expectations by delivering earnings of $1.28 per share against an estimate of $1.15, resulting in a surprise of +11.30% [12]. - Over the past four quarters, Esab has consistently beaten consensus EPS estimates [13]. Conclusion - While Esab does not appear to be a strong candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [16].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Beacon Roofing Supply, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The consensus estimate predicts a quarterly loss of $0.21 per share, reflecting a year-over-year change of -151.2% [3]. - Expected revenues are $1.91 billion, which is a decrease of 0.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.06% higher in the last 30 days, indicating a slight reassessment by analysts [4]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, leading to a negative Earnings ESP of -233.87% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation from consensus estimates, with positive readings being more predictive of earnings beats [6][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have shown a nearly 70% success rate in delivering positive surprises [8]. Historical Performance - In the last reported quarter, Beacon Roofing was expected to earn $1.67 per share but delivered $1.65, resulting in a surprise of -1.20% [12]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [13]. Conclusion - Beacon Roofing does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock [16].

Company Overview - Gevo, Inc. (GEVO) is anticipated to report a year-over-year increase in earnings due to higher revenues for the quarter ended March 2025, with a consensus outlook indicating a quarterly loss of $0.07 per share, reflecting a +12.5% change from the previous year [1][3] - Revenues are expected to reach $30.93 million, representing a significant increase of 675.2% compared to the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 23.08% higher in the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4] - The Most Accurate Estimate for Gevo is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -14.29%, suggesting a bearish outlook from analysts [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with a strong predictor being a positive Earnings ESP combined with a favorable Zacks Rank [6][8] - Gevo currently holds a Zacks Rank of 2 (Buy), but the negative Earnings ESP complicates the prediction of an earnings beat [11] Historical Performance - In the last reported quarter, Gevo was expected to post a loss of $0.11 per share but delivered a loss of $0.09, resulting in a surprise of +18.18% [12] - Over the past four quarters, Gevo has beaten consensus EPS estimates two times [13] Industry Comparison - Clearway Energy (CWEN), another player in the alternative energy sector, is expected to report earnings per share of $0.30 for the same quarter, indicating a year-over-year change of -1,400%, with revenues projected at $310.81 million, up 18.2% from the previous year [17] - Clearway Energy's consensus EPS estimate has been revised 8.5% higher recently, and it has an Earnings ESP of 108.50%, suggesting a likely earnings beat [18]